THE CHALLENGE OF
MENTAL HEALTH
Mental health conditions impact a significant portion of the population, resulting in suffering and reduced quality of life. We are committed to discovering innovative solutions for diseases such as depression, autism, pain, and addiction.
PIONEERING IN
MENTAL HEALTH
We are dedicated to conducting research and uncovering novel therapies that can have a substantial impact on peoples' lives. Through our rational approach to addressing these conditions, we aim to achieve significant progress in the field.
DRIVING INNOVATION IN
MENTAL HEALTHCARE
The mental health market is experiencing significant growth, with a critical demand for innovative and efficient treatments. Our mission is to progress the treatment of mental health conditions, including neuropsychiatric disorders.
The Growing Market for Neuroscience
The field of neuroscience has seen significant growth in recent years, driven by advances in technology and increased understanding of the brain and its functions. The global mental health market was valued at over $380 billion in 2020, and is estimated to exceed $530 billion by 2030.
Mental health problems are characterized by the absence of a positive emotion, low mood, and a range of associated cognitive, physical, emotional, and behavioral symptoms. It is a very common condition that affects 1 in every 5 individuals. The factors such as genes as well as stress and brain chemistry lead to depression. According to the WHO, more than 264 million people of all ages suffered from depression in 2020. Depression is a leading cause of disability worldwide, and is a major contributor to the overall global burden of disease.
Pharmaceutical companies are keen to find effective treatments for many neurological and psychiatric conditions. Developing effective treatments for these conditions requires cutting-edge research, innovative approaches, and a deep understanding of the underlying biological mechanisms.
Changing the Landscape of Healthcare
Neurentis is on a mission to change the landscape of healthcare by revolutionizing the way we treat neuropsychiatric diseases. We believe that by developing novel drugs that effectively target rational mechanisms, we can help to address the growing problem of these conditions and improve the health and well-being of millions of people worldwide.
Mental Health: A Condition that Knows No Bounds
Regardless of wealth or status, poor mental health is a condition that can impact anyone. Mental health is a crucial aspect of overall well-being, affecting one's emotions, thoughts, and behaviors. Poor mental health can have a debilitating impact on individuals, preventing them from functioning at their full potential.
The Unmet Need for Better Neuroscience Treatments
Mental health conditions, including stress, post-traumatic stress disorder, anxiety, schizophrenia, psychiatric disorders, memory loss, addiction, and even rare conditions like Prader-Willi Syndrome, affect a significant portion of the global population. The burden of these conditions is substantial. Patients continue to struggle, and the quest for more effective solutions remains ongoing. According to the WHO, millions of people of all ages suffered from various neuropsychiatric conditions in recent years. It's a widespread challenge that touches the lives of countless individuals.
Breakthrough solutions to massive problems
Despite existing treatments, many people with mental conditions continue to struggle, making the need for new, effective and safer options crucial. The development of novel treatments for psychiatric disorders can help to improve the quality of life for sufferers and their families by offering a solution that can effectively manage the symptoms of these conditions.
Experienced team & advisors
Neurentis is managed by a team of pharma industry executives. We have a detailed knowledge of science and medicine, know how to develop and commercialise pharmaceuticals, we have a large network of contacts in the industry and are driven by passion and ethical values. We have the support of expert advisors and organisations.
Large & sustainable market
The increasing awareness surrounding mental health have led to greater demand for effective treatments, creating a large and growing market for pharmaceutical companies. Furthermore, depression and other psychiatric disorders often require long-term treatment, providing a sustained demand for drugs to address these conditions. This, combined with the limited number of effective treatments currently available, makes the market for novel and effective drugs in this area attractive and sustainable.
